US Patent 8486890 Amylin derivatives

Patent 8486890 was granted and assigned to Novo Nordisk on July, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8486890

Date of Patent

July 16, 2013

Patent Application Number

12282042

Date Filed

March 15, 2007

Patent Citations Received

‌

US Patent 12018059 Human amylin analog polypeptides and methods of use

Patent Primary Examiner

‌

Gyan Chandra

Patent abstract

The present invention relates to novel amylin derivatives having a protracted action profile, to pharmaceutical compositions comprising these derivatives and to the use of the derivatives for the treatment of diseases related to obesity, diabetes and other metabolic disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8486890 Amylin derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API